APrevent Medical Inc. Secures $6 Million in Series D Funding Led by Taiwania Capital

APrevent Medical Inc. is thrilled to announce the successful Series D funding round led by Taiwania Capital, a leading venture capital firm in Taiwan , backed by Taiwan’s public and private sectors which focus on investing in innovative companies in High-tech and Biotech fields.

2024-03-29

Partnership with Endotherapeutics Pty. Ltd. in Australia

Partnership with Endotherapeutics Pty. Ltd. in Australia

2023-11-23

VOIS TFDA Approval

VOIS TFDA Approval

2023-06-27

2023 ELS

2023 ELS

2023-06-26

APrevent signed distribution agreement with SPIGGLE & THEIS

APrevent signed distribution agreement with SPIGGLE & THEIS

2023-05-26

2023 ATLife

2023 ATLife

2023-04-17

Loading...